{"entity":{"type":"insider","cik":"0001800668","url":"/insider/0001800668","json_url":"/insider/0001800668.json","name":"Anders Jack","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":31,"first":"2020-10-08","last":"2026-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Anders Jack","source":"filing","n_filings":31,"first_seen":"2020-10-08","last_seen":"2026-06-26"}],"transactions":[{"id":5786816,"accession":"0001610717-26-000296","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001610717-26-000296","line_url":"/filing/0001610717-26-000296","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":168.330223025,"price_display":"168.33","price_state":"stated","total_value":3366604.4605,"total_display":"3,366,604.46","total_whole":"3,366,604","shares_owned_after":129220.0,"shares_owned_after_display":"129,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-26","scope":"insider","n_lines":4},{"id":5872129,"accession":"0001610717-26-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000244","line_url":"/filing/0001610717-26-000244#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2722.0,"shares_display":"2,722","price_per_share":156.1192,"price_display":"156.12","price_state":"stated","total_value":424956.4624,"total_display":"424,956.46","total_whole":"424,956","shares_owned_after":123269.0,"shares_owned_after_display":"123,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-18","scope":"insider"},{"id":5917301,"accession":"0001610717-26-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000128","line_url":"/filing/0001610717-26-000128#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2753.0,"shares_display":"2,753","price_per_share":99.4804,"price_display":"99.48","price_state":"stated","total_value":273869.5412,"total_display":"273,869.54","total_whole":"273,870","shares_owned_after":125512.0,"shares_owned_after_display":"125,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5813933,"accession":"0001610717-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-26-000012","line_url":"/filing/0001610717-26-000012#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":98.0,"price_display":"98.00","price_state":"stated","total_value":980000.0,"total_display":"980,000.00","total_whole":"980,000","shares_owned_after":108065.0,"shares_owned_after_display":"108,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider"},{"id":4675424,"accession":"0001610717-25-000420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000420","line_url":"/filing/0001610717-25-000420#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3104.0,"shares_display":"3,104","price_per_share":77.0904,"price_display":"77.09","price_state":"stated","total_value":239288.6016,"total_display":"239,288.60","total_whole":"239,289","shares_owned_after":108065.0,"shares_owned_after_display":"108,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-18","scope":"insider"},{"id":5218347,"accession":"0001610717-25-000404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-25-000404","line_url":"/filing/0001610717-25-000404#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5418.0,"shares_display":"5,418","price_per_share":74.0,"price_display":"74.00","price_state":"stated","total_value":400932.0,"total_display":"400,932.00","total_whole":"400,932","shares_owned_after":110994.0,"shares_owned_after_display":"110,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4181845,"accession":"0001610717-25-000377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-25-000377","line_url":"/filing/0001610717-25-000377#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":640000.0,"total_display":"640,000.00","total_whole":"640,000","shares_owned_after":110994.0,"shares_owned_after_display":"110,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider"},{"id":4385078,"accession":"0001610717-25-000346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000346","line_url":"/filing/0001610717-25-000346#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2320.0,"shares_display":"2,320","price_per_share":45.8249,"price_display":"45.82","price_state":"stated","total_value":106313.768,"total_display":"106,313.77","total_whole":"106,314","shares_owned_after":110994.0,"shares_owned_after_display":"110,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4993680,"accession":"0001610717-25-000326","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001610717-25-000326","line_url":"/filing/0001610717-25-000326#line-6","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5238.0,"shares_display":"5,238","price_per_share":40.1742,"price_display":"40.17","price_state":"stated","total_value":210432.4596,"total_display":"210,432.46","total_whole":"210,432","shares_owned_after":113314.0,"shares_owned_after_display":"113,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-04","scope":"insider"},{"id":4993658,"accession":"0001610717-25-000326","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001610717-25-000326","line_url":"/filing/0001610717-25-000326#line-3","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4762.0,"shares_display":"4,762","price_per_share":40.0168,"price_display":"40.02","price_state":"stated","total_value":190560.0016,"total_display":"190,560.00","total_whole":"190,560","shares_owned_after":113314.0,"shares_owned_after_display":"113,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":4516181,"accession":"0001610717-25-000239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000239","line_url":"/filing/0001610717-25-000239#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":39.83,"price_display":"39.83","price_state":"stated","total_value":86431.1,"total_display":"86,431.10","total_whole":"86,431","shares_owned_after":113314.0,"shares_owned_after_display":"113,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":5218314,"accession":"0001610717-25-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000079","line_url":"/filing/0001610717-25-000079#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1864.0,"shares_display":"1,864","price_per_share":39.0403,"price_display":"39.04","price_state":"stated","total_value":72771.1192,"total_display":"72,771.12","total_whole":"72,771","shares_owned_after":115006.0,"shares_owned_after_display":"115,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":3222376,"accession":"0001610717-24-000543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000543","line_url":"/filing/0001610717-24-000543#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2635.0,"shares_display":"2,635","price_per_share":45.4038,"price_display":"45.40","price_state":"stated","total_value":119639.013,"total_display":"119,639.01","total_whole":"119,639","shares_owned_after":96470.0,"shares_owned_after_display":"96,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":2488850,"accession":"0001610717-24-000507","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000507","line_url":"/filing/0001610717-24-000507#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.2979,"price_display":"50.30","price_state":"stated","total_value":502979.0,"total_display":"502,979.00","total_whole":"502,979","shares_owned_after":98932.0,"shares_owned_after_display":"98,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-15","scope":"insider"},{"id":2969081,"accession":"0001610717-24-000489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000489","line_url":"/filing/0001610717-24-000489#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2244.0,"shares_display":"2,244","price_per_share":44.1853,"price_display":"44.19","price_state":"stated","total_value":99151.8132,"total_display":"99,151.81","total_whole":"99,152","shares_owned_after":98932.0,"shares_owned_after_display":"98,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-18","scope":"insider"},{"id":2921161,"accession":"0001610717-24-000351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000351","line_url":"/filing/0001610717-24-000351#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1893.0,"shares_display":"1,893","price_per_share":37.3876,"price_display":"37.39","price_state":"stated","total_value":70774.7268,"total_display":"70,774.73","total_whole":"70,775","shares_owned_after":101176.0,"shares_owned_after_display":"101,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2969051,"accession":"0001610717-24-000229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000229","line_url":"/filing/0001610717-24-000229#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.026,"price_display":"40.03","price_state":"stated","total_value":400260.0,"total_display":"400,260.00","total_whole":"400,260","shares_owned_after":101959.0,"shares_owned_after_display":"101,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-03","filed_date":"2024-05-03","scope":"insider"},{"id":2567701,"accession":"0001610717-24-000170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000170","line_url":"/filing/0001610717-24-000170#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1261.0,"shares_display":"1,261","price_per_share":31.5832,"price_display":"31.58","price_state":"stated","total_value":39826.4152,"total_display":"39,826.42","total_whole":"39,826","shares_owned_after":101959.0,"shares_owned_after_display":"101,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":7909382,"accession":"0001610717-23-000416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000416","line_url":"/filing/0001610717-23-000416#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1775.0,"shares_display":"1,775","price_per_share":25.9018,"price_display":"25.90","price_state":"stated","total_value":45975.695,"total_display":"45,975.70","total_whole":"45,976","shares_owned_after":76416.0,"shares_owned_after_display":"76,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8715409,"accession":"0001610717-23-000292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000292","line_url":"/filing/0001610717-23-000292#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1427.0,"shares_display":"1,427","price_per_share":31.3106,"price_display":"31.31","price_state":"stated","total_value":44680.2262,"total_display":"44,680.23","total_whole":"44,680","shares_owned_after":53667.0,"shares_owned_after_display":"53,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":8305842,"accession":"0001610717-23-000259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-23-000259","line_url":"/filing/0001610717-23-000259#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":35.0546,"price_display":"35.05","price_state":"stated","total_value":701092.0,"total_display":"701,092.00","total_whole":"701,092","shares_owned_after":55094.0,"shares_owned_after_display":"55,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":8616665,"accession":"0001610717-23-000193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000193","line_url":"/filing/0001610717-23-000193#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1249.0,"shares_display":"1,249","price_per_share":24.891,"price_display":"24.89","price_state":"stated","total_value":31088.859,"total_display":"31,088.86","total_whole":"31,089","shares_owned_after":55094.0,"shares_owned_after_display":"55,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":8350968,"accession":"0000899243-23-009376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009376","line_url":"/filing/0000899243-23-009376#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":665.0,"shares_display":"665","price_per_share":21.78,"price_display":"21.78","price_state":"stated","total_value":14483.7,"total_display":"14,483.70","total_whole":"14,484","shares_owned_after":55233.0,"shares_owned_after_display":"55,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":6498827,"accession":"0001567619-22-021930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-021930","line_url":"/filing/0001567619-22-021930#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":658.0,"shares_display":"658","price_per_share":22.9405,"price_display":"22.94","price_state":"stated","total_value":15094.849,"total_display":"15,094.85","total_whole":"15,095","shares_owned_after":29298.0,"shares_owned_after_display":"29,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6400992,"accession":"0001567619-22-017689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-017689","line_url":"/filing/0001567619-22-017689#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":449.0,"shares_display":"449","price_per_share":19.0426,"price_display":"19.04","price_state":"stated","total_value":8550.1274,"total_display":"8,550.13","total_whole":"8,550","shares_owned_after":29956.0,"shares_owned_after_display":"29,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-21","scope":"insider"},{"id":6400831,"accession":"0001567619-22-013250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013250","line_url":"/filing/0001567619-22-013250#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":406.0,"shares_display":"406","price_per_share":17.7495,"price_display":"17.75","price_state":"stated","total_value":7206.297,"total_display":"7,206.30","total_whole":"7,206","shares_owned_after":20405.0,"shares_owned_after_display":"20,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-22","scope":"insider"},{"id":6188104,"accession":"0001567619-22-007323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-007323","line_url":"/filing/0001567619-22-007323#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159.0,"shares_display":"159","price_per_share":18.6162,"price_display":"18.62","price_state":"stated","total_value":2959.9758,"total_display":"2,959.98","total_whole":"2,960","shares_owned_after":19875.0,"shares_owned_after_display":"19,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-21","scope":"insider"},{"id":5417999,"accession":"0001567619-21-022406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022406","line_url":"/filing/0001567619-21-022406#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170.0,"shares_display":"170","price_per_share":24.41,"price_display":"24.41","price_state":"stated","total_value":4149.7,"total_display":"4,149.70","total_whole":"4,150","shares_owned_after":8434.0,"shares_owned_after_display":"8,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":4699633,"accession":"0001567619-21-017417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-017417","line_url":"/filing/0001567619-21-017417#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166.0,"shares_display":"166","price_per_share":30.02,"price_display":"30.02","price_state":"stated","total_value":4983.32,"total_display":"4,983.32","total_whole":"4,983","shares_owned_after":8192.0,"shares_owned_after_display":"8,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":4276772,"accession":"0001567619-21-012487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012487","line_url":"/filing/0001567619-21-012487#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160.0,"shares_display":"160","price_per_share":34.1241,"price_display":"34.12","price_state":"stated","total_value":5459.856,"total_display":"5,459.86","total_whole":"5,460","shares_owned_after":8358.0,"shares_owned_after_display":"8,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-22","scope":"insider"},{"id":3069976,"accession":"0001567619-20-017887","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-017887","line_url":"/filing/0001567619-20-017887#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":440000.0,"total_display":"440,000.00","total_whole":"440,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-13","filed_date":"2020-10-15","scope":"insider"},{"id":2271592,"accession":"0001567619-20-017693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-017693","line_url":"/filing/0001567619-20-017693#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800668","owner_name":"Anders Jack","owner_display_name":"Anders Jack","owner_url":"/insider/0001800668","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-06","filed_date":"2020-10-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Officer (Chief Financial Officer)","n_filings":31,"first_seen":"2020-10-08","last_seen":"2026-06-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001800668","retrieved_at":"2026-08-22T14:33:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}